Latest News

High-density lipoprotein (HDL) has become known as “good cholesterol” because it helps reduce risk of stroke and heart attack. However, new research found that both high and low levels of HDL could increase a person’s risk of premature death.
Rocco Perla Explains the Importance of Patient-Centered Reform Conversations
Rocco Perla, president of Health Leads, explained that not only do stakeholders in the health system need to come together, but that the conversation also must be patient-centered to truly make headway in care reform.
Despite coverage gains since the implementation of the Affordable Care Act, groups at risk of being uninsured before the law continue to have higher uninsured rates.
Podcast: Margaret E. O'Kane Discusses Her Pioneering Work on Quality Measurement
In this podcast Margaret E. O'Kane discusses how she got into quality measurement, the beginning of the National Committee for Quality Assurance, and the next frontier in quality measurement.
High persistent spending is unusually common during the year before death, researchers find.
Programs that seek to lower hospital admissions rates may also reduce readmissions, even though patients in communities adopting the programs tend to be sicker when hospitalized, according to a recent study in Health Affairs.
This Week in Managed Care: August 27, 2016
This week in managed care, the top stories included new reports on a 10-year experiment in payment reform, more results from the early years of the Affordable Care Act, and findings on employee wellness programs.
Researchers found a dose-response relationship for several cancers involved in eating, meaning the higher the weight, the greater risk of cancer.
Advances in genetic technologies have a great potential to be used to advance treatments, especially through personalized medicine. However, there are concerns that disadvantaged groups do not have access to these advances.
Margaret E. O'Kane has been making lasting impacts on healthcare quality measurement for years. But when she founded the National Committee for Quality Assurance, the organization was sometimes underestimated and not taken seriously.
A review of our peer-reviewed research, in the healthcare and mainstream press.
What we're reading, August 26, 2016: the middle class is burdened with increasing healthcare costs; how much do voters need to know about presidential candidates' health; and honoring the end-of-life wishes of patients with dementia.
The FDA has several projects under its wings that can improve the regulatory aspect of drug development and healthcare overall.
Dr Don Berwick Highlights the Lessons From AF4Q
In a series of video interviews, Donald M. Berwick, MD, MPP, president emeritus and senior fellow of the Institute for Healthcare Improvement, discussed the lessons learned from the Aligning Forces for Quality initiative.

From the Journals

The authors found that comorbidity burden and the direction of behavioral change influence the relationship between adherence and medical spend. This could affect the cost-benefit considerations of medication adherence programs.
This issue of Evidence-Based Oncology is dedicated to understanding the implications, scope, and opportunities within the realm of cost sharing in oncology.
Financial burden is a potential nonclinical adverse event in cancer patients. As patients, especially those in the lower income ranges and the middle class, struggle to meet their medical bills, the likelihood of them skipping doses or doctor’s visits is quite high.
Reducing barriers to hematopoetic stem cell (HPC) transplant is critical to supporting patients with one of the more than 70 blood cancers and other blood disorders (such as leukemia, lymphoma, and myloplastic dysplasia) for which a transplant may be the only therapy remaining with curative intent.
Young adult (YA) cancer survivors are hit the hardest in the wallet by their treatment. The average net worth of YAs who have received grants from The Samfund is a staggering –$35,000, while their counterparts in the general population is $68,000
Precision oncology, or the clinically and financially efficient use of genomically matched treatments and clinical trials, is evolving as a potentially important starting point for cancer care within successful alternative payment models.
Since 2005, American Cancer Society has sponsored the Health Insurance Assistance Service, a unique initiative to help cancer patients navigate the private coverage system and to educate policy makers about how coverage works for patients with this serious and chronic condition.
When it comes to health coverage, most Americans face an unnerving reality—they have no idea what is covered under their health insurance policy until after they are affected by illness or disease.
A study by researchers at the University of California, Berkeley, found that patients who have access to the prices charged by a testing laboratory, as well as reference pricing, choose lower-cost laboratories, a move that results in overall cost savings.
Diabetes Compendium
HCV Compendium
Oncology Compendium
Reimbursement Compendium
Know Your News
HF Compendium
Managed Care Cast
Managed Care Cast
Healthcare 2020

NEW! Focus on 2020: What does the Future of Healthcare Hold?

Most Popular

Upcoming Partner Events
August 23-24, 2016
Chicago, IL
October 19-20, 2016
Scottsdale, AZ

AJMC Strategic Alliance